PRTN3 and rheumatoid arthritis: However, there was no difference in the frequency of IL-17-producing CD4 T cells in the peripheral blood between ACPA +ve (1.00% (0.36 to 1.72)) and ACPA -ve (0.97% (0.38 to 1.94)) RA patients.